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Richardson et al., page 5
Genome-wide association studies (GWASs) have success-
fully identified significant variants associated with
a variety of complex diseases and traits. However, func-
tional evidence to explain the relevance of these variants
to the associated disease is, for the most part, lacking. For
example, GWASs have identified hundreds of variants
associated with lipid phenotypes, but little is known
about how these variants alter lipid metabolism or
response. In this issue, Richardson et al. investigate
a SNP in high linkage disequilibrium (LD) with variants
identified in previous GWASs as being associated with
lipid traits. This variant, rs13702, resides in the miR-410
recognition element seed site within in the 30 UTR of
lipoprotein lipase (LPL) and alters the ability of miR-410
to cleave LPL mRNA. The authors quantified the effect
of the minor and major alleles by using a luciferase
reporter assay; the major T allele caused a reduction of
the LPL reporter in a dosage-dependent manner. Meta-
analysis demonstrated that rs13702 is associated with
triacylglycerols (TAGs) and high-density lipoproteins;
moreover, an association between rs13702 with dietary
polyunsaturated fatty acids (PUFAs) and resulting TAG
concentrations was identified. This evidence suggests
a model wherein dietary intake of PUFAs induces LPL tran-
scription and the resulting LPL transcript is regulated by
miR-410 in an allele-specific manner. For the major T
allele, in which miR-410-mediated cleavage of LPL is
more effective, reduced transcript and protein accumula-
tion might lead to reduced TAG concentration. As studies
begin to probe the functional relevance of GWAS variants,
more complete pictures of phenotypic variation and
disease will emerge.Chimeric Gene Explains Association between
FCGR3B and SLE
Mueller et al., page 28
Systemic lupus erythematosus (SLE) has been associated
with reduced clearance of immune complexes and reduced
copy number of FCGR3B. Within the FCGR2/3 locus, there
are four genes (e.g., FCGR3B and FCGR2C) encoding acti-
vating receptors and one gene (FCGR2B) encoding an1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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Theinhibitory receptor; the resultant proteins help to clear or
prevent clearance of immune complexes, respectively.
The close distance and high similarity between these genes
has confounded the ability to determine the precise
sequence of this region. To approach this challenge, Muel-
ler et al. utilized a variety of techniques to determine the
sequence of this complicated region in healthy individuals
and in individuals with FCGR3B deletions. In individuals
with FCGR3B deletions, the 50 regulatory region of the
upstream activating gene, FCGR2C, is brought into close
proximity to the coding region of the inhibitory gene,
FCGR2B. The expression of this chimeric gene leads to
ectopic accumulation of FCGR3B in the immune system’s
natural killer (NK) cells, a process which probably disrupts
the normal NK-mediated clearance of immune complexes.
This model provides mechanistic evidence linking reduced
FCGR3B copy number and immune dysfunction associated
with SLE.Many Malay Genomes
Teo et al., page 52
Although the 1000 Genomes Project has revolutionized
the ways in which population genetics can be studied,
its very design precludes high-confidence detection
of rare variants. Moreover, the scope of the project,
although by far the most comprehensive to date, is
such that several populations were not included or were
included in very low numbers. In this issue, Teo et al.
report on the high-coverage, whole-genome sequencing
of nearly 100 individuals from one such population: the
Malays, an Austronesian-speaking people of South Asia.
Although the number of individuals sequenced is lower
than that of projects such as 1000 Genomes, the study
generated a rich data set that will only be augmented in
the future. Indeed, through their analysis, the authors
uncovered many previously undescribed rare variants.
This information will be very useful in future studies on
this or related populations, such as genome-wide associa-
tion and fine-mapping studies that require imputation. In
addition to providing a rich genomic resource for the
study of this population, the authors’ work also provides
a great tool for those investigators interested in devel-
oping new methods and techniques in population-level
genetics.y of Human Genetics. All rights reserved.
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AKTing Up in Cowden Syndrome
Orloff et al., page 76
Mutations in PTEN cause the majority of cases of Cowden
syndrome, a condition that is characterized by the pres-
ence of multiple hamartomas and that carries a high risk
of specific types of cancer. For several affected individuals,
however, the genetic cause is unknown. Mutations that
affect proteins downstream of PTEN, including several
that are known to function aberrantly in nonfamilial
cancers, would therefore appear to be good candidates. In
this issue, Orloff et al. show that this is indeed the case
by identifying several germline mutations in AKT1 and
PIK3CA (which encodes the catalytic subunit of PI3K)
in affected individuals who lacked a genetic diagnosis.
This finding fits in nicely with recent work that
showed that somatic mosaic mutations affecting these
same genes cause rare non-neoplastic overgrowth disor-
ders. Further study is needed for better understanding the
spectrum of mutations that have been identified in these
genes. One question is whether mutations that are
observed in tumors and overgrowth syndromes are too
deleterious to be tolerated in the earliest stages of develop-
ment. The wealth of knowledge that exists about this bio-
logical pathway, coupled with the availability of targeted
therapeutics, suggests that there soon might be new treat-
ment options for this subset of individuals affected by
Cowden syndrome.2 The American Journal of Human Genetics 92, 1–2, January 10, 2013Don’t Forget about the Introns
Flanagan et al., page 131
Recent studies have identified an abundance of disease-
causing mutations by exome sequencing, a technique
that focuses on the identification of variants in coding
regions. Because of the many successes brought about by
this method, one might overlook the notion that muta-
tions outside of coding regions can also contribute to
disease. In this issue, Flanagan et al. found evidence that
a subset of individuals suffering from hyperinsulinaemic
hypoglycemia had biochemical defects in ABCC8 or
HADH. However, exome sequencing failed to identify
mutations in either underlying gene. Recognizing the limi-
tations of exome sequencing, they used next-generation
sequencing to explore these two genes more thoroughly.
This analysis uncovered deep intronic mutations that
were missed by both exome and Sanger sequencing. In
these cases, the additional mutations in deep intronic
regions created cryptic splice sites that led to the accumu-
lation of mutant transcripts in the fibroblasts of affected
individuals. Notably, these mutations accounted for
a substantial proportion of affected individuals within
this cohort. This study serves as a cautionary tale: when
additional evidence suggests that a gene or region is
involved in a disease, don’t rule it out until the entire
sequence, introns and all, has been double-checked for
mutations.
